Delivery Order SPE2DB24D9315-SPE2DB24FFWGL

Award Date 7/1/24
Potential Completion Date 7/23/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,497.94 contract is for the delivery of OCALIVA 5 MG TABLET 30S, with a completion date of September 10, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $35,004.76, is for the delivery of Ocaliva 10 mg tablets on a firm-fixed-price basis, with a period of performance through May 13, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract has a ceiling value of $17,497.94 and an ultimate completion date of April 17, 2024. DMS Pharmaceutical Group is the prime contractor and will be delivering Ocaliva 5 mg tablets to support the medical supply needs of military health facilities. This delivery order is part of a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $8,748.97, is for the supply of the pharmaceutical product Ocaliva 5 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $26,251.35 contract is for the supply of OCALIVA 10 MG TABLET 30S, with a period of performance through September 27, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $26,639.55 contract is for the supply of the drug Ocaliva 5 mg tablets, with a completion date of September 18, 2023. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA, under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $69,991.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,497.94 firm fixed-price contract is for the delivery of the pharmaceutical product OCALIVA 5 MG TABLET 30S, with a performance period through June 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $17,497.94, is for the delivery of the pharmaceutical product Ocaliva 5 mg tablets. The contract has a completion date of May 6, 2024 and does not have a set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,497.94 firm fixed-price contract is for the delivery of the pharmaceutical product OCALIVA 5 MG TABLET 30S. The contract has an ultimate completion date of June 21, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
  • SPE2DB24D9315
    Indefinite Delivery Contract
  • SPE2DB24D9315-SPE2DB24FFWGL
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,497.94 contract is for the delivery of Ocaliva 5 mg tablets. The order has a completion date of July 23, 2024 and is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a wide range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group specializes in providing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to federal agencies, primarily the Department of Defense and Department of Veterans Affairs. The contract has no set-aside designation.

Generated 9/30/24, 11:14 AM